Volume 24, Issue 3 (Jun 2016)                   JSSU 2016, 24(3): 261-268 | Back to browse issues page

XML Persian Abstract Print


Abstract:   (13026 Views)

Introduction: Vitamin D deficiency (VDD) causes same diseases such as osteoporosis, osteomalacia, and fractures, and also it is shown that Vitamin D deficiency could lead to some cardiovascular disease, diabetes and many types of cancer. Therefore, this study aimed to determine the frequency of vitamin D deficiency among referring to laboratories in Eyvan city during 2015 and 2016.

Methods: A cross-sectional study was conducted in 2014 and 2015 on patients who were referred to the laboratories at Eyvan city. Serum levels of 25OHD were determined using a ELISA assay. The data were analyzed SPSS 17 software using descriptive and analytical tests.

Results: Out of 2 919 participants, 2053 patients were women. The average age was 36.25±17.1 (range 1-92) yrs. The overall prevalence of vitamin D deficiency in the patients admitted to the medical laboratories was estimated that approximately 62%. The prevalence severe and moderate vitamin D deficiency was calculated 10.4 and 51.5, respectively. The prevalence of vitamin D deficiency among the ages 1-6, 7-18, 19-60 and over 60 years was estimated 45%, 59%, 64% and 58%, respectively. The mean vitamin D concentration was 36.25±18.79 ng/ml. The relationship between deficiency of vitamin D with age and gender was statistically significant (P=000).

Conclusion: Vitamin D deficiency prevalence is high, so the intervention plan seems essential to avoid complications of vitamin D deficiency such as medication treatment and establishing nationally-mandated food fortification programs to enhance the intake of vitamin D.

Full-Text [PDF 500 kb]   (1972 Downloads)    
Type of Study: Original article | Subject: Nutrition
Received: 2016/04/13 | Accepted: 2016/07/9 | Published: 2016/08/9

References
1. Nowson CA, McGrath JJ, Ebeling PR, Haikerwal A, Daly RM, Sanders KM, et al. Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust. 2012; 196(11): 686-87.
2. Wintegers ES, Magginis S, Hormig DH. Contribution of selected vitamins and trace elements to immune function. Ann nutrmetab 2007; 51(4): 301-23.
3. Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 1995; 61(3): 638S-645S.
4. Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 2004; 158(6): 531-37.
5. Gessner BD, Plotnik J, Muth PT. 25- hydroxyvitamin D levels among healthy children in Alaska. J Pediatr 2003; 143(4): 434-37.
6. Holick MF. Vitamin D deficiency. The New England Journal of Medicine 2007; 357(3): 266-81.
7. Heshmat R, Mohammad K, Majdzadesh SR, Forouzanfar MH, Bahrami A, Ranjbaromarani GH, et al. Vitamin d deficiency in iran: A Multi-center study among different urban areas. Iranian J Public Health 2008; (1): 72-8.
8. Sullivan SS, Rosen CJ, Halteman WA, ChenTC, Holick MF. AdoJescent girls in Maine atrisk for vitamin D insufficiency. J Am Diet Assoc 2005; 105(6): 971-974.
9. Kochupillai N. The physiology of vitamin D: current concepts. Indian J Med Res. 2008; 127(3): 256-62.
10. Hagenau T, Vest R, Gissel TN, Poulsen CS, Erlandsen M, Mosekilde L, et al. Global vitamin D levels in relation to age,gender, skin pigmentation and latitude: anecologic meta-regression analysis. Osteoporos Int 2009; 20(1): p. 133-40.
11. Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 2007; 66(9): 1137-42.
12. Trump DL, Deeb K, Johnson CS. Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy. Cancer 2010; 16(1): 1-9.
13. Rucker D, Allan JA, Fick GH, Hanley DA. Vitamin D insufficiency in a population of healthy western Canadians. CMAJ 2002; 166(12): 1517-24.
14. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab 2012; 97(4): 1153-58.
15. Saedinea A, Larijani B, Jalalinea S, Farzadfar F, Keshtkar F, Rezae A, et al. Evaloation of prevalence deficiency of vitamin D in Iranian population the province during 1990-2010. Iran J Diabetes Metab 2013; 12(6): 574-84. [Persian]
16. Hashemipour S, Larijani B, Adibi H, Javadi E, Sedaghat M, PajouhiM, et al. Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health 2004; 4(1): 1.
17. Alizadeh Z, Hlbchy F, RadjabianTabesh M. The prevalence of vitamin D deficiency inindividuals with aBMIhigher than25 kg /m and its association with demographic and anthropometricindices. Tehran Univ Med J (TUMJ) 2015; 73(6): 447-55.
18. Hovsepian S, Amini M, Aminorroaya A, Amini P, Iraj B. Prevalenceof vitamin D deficiency among adult population of IsfahanCity, Iran. J Health Popul Nutr 2011; 29(2): 149-55.
19. Niafar M, Bahrami A, Aliasgharzadeh A, Aghamohammadzadeh N, Najafipour F, Mobasseri M. Vitamin D status in healthy postmenopausal Iranian women. J Res Med Sci 2009; 14(3): 171-77.
20. Nakamura K, Nashimoto M, Hori Y, Muto K, Yamamoto M. Serum 25-hydroxyvitamin D levels in active women of middle and advanced age in a rural community in Japan. Nutrition 1999; 15(11): 870-73.
21. Salek M, Rafati H, Hashemipour M, Ardestani PM, Nezhadnik H, Amini M, et al. Is Vitamin D Deficiency Prevalent in Healthy 6-yearold Children in Isfahan City? J Isfahan Med School 2007; 25(85): 95-103.

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.